DNMT3A and acute myeloid leukemia: Clinically, AML patients with HOXB3 hypomethylation had unique clinical subtypes and cytogenetic/molecular patterns, including FAB-M5, normal karyotype, cytogenetic/molecular-intermediate risks, and mutations in FLT3-ITD, NPM1 and DNMT3A.